5Moland ES, Hanson ND, Black JA,et al. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 [J].J Clin Microbiol, 2006,44 ( 9 ) : 3318-3324.
6Yu WL, Chuang YC, Wahher-Rasmussen J. Extended- spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control [ J ]. J Mi- crobiol Immunol Infect, 2006,39 (4) : 264-277.
7Kader AA, Angamuthu KK, Kamath KA, et al. Modi- fied double-disc test for detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae [ J ]. Br J Biomed Sci, 2006,63 ( 2 ) : 51- 54.
8Bagattini M, Crivaro V, Di Popolo A,et al. Molecular epidemiology of extended-spectrum beta-lacta-mase-producing KlebsieUa pneumoniae in a neonatal intensive care unit [ J ]. J Antimicrob Chemother, 2006,57 (5) :979-982.
9Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control[ J]. J Infect, 2003,47(4) : 273-295.
10Arpin C, Dubois V, Coulange L,et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers [ J ]. Antimicrob Agents Chemother, 2003, 47 ( 11 ) : 3506- 3514.
